Clinical Trials Directory

Trials / Conditions / Pancreatic Neuroendocrine Carcinoma

Pancreatic Neuroendocrine Carcinoma

9 registered clinical trials studyying Pancreatic Neuroendocrine Carcinoma — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingMulticenter Trial of ESK981 in Patients With Select Solid Tumors
NCT05988918
University of Michigan Rogel Cancer CenterPhase 2
CompletedAssessment of What Patients and Healthcare Providers Value
NCT04483349
M.D. Anderson Cancer Center—
Active Not RecruitingNivolumab and Ipilimumab in Treating Patients With Rare Tumors
NCT02834013
National Cancer Institute (NCI)Phase 2
Active Not RecruitingCisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (
NCT02595424
ECOG-ACRIN Cancer Research GroupPhase 2
CompletedAntitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitin
NCT02230176
Gustave Roussy, Cancer Campus, Grand ParisPhase 2
CompletedZiv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With
NCT02101918
National Cancer Institute (NCI)Phase 2
RecruitingAssociation Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and
NCT01365169
M.D. Anderson Cancer CenterN/A
UnknownDiagnosis of PCL With EUS-FNA and Cross-sectional Imaging - A Report of Accuracy
NCT03884179
Sahlgrenska University Hospital—
RecruitingCollecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Dis
NCT00830557
Mayo Clinic—